Navigation Links
HealthEdge Receives $13 Million Investment Commitment to Fund Significant Growth
Date:4/22/2008

HealthEdge's Revolutionary Software Platform-HealthRules(R)-Poised to

Change the Rules for Healthcare Payors

BURLINGTON, Mass., April 22 /PRNewswire/ -- HealthEdge, the leading provider of next-generation claims and benefit administration, business intelligence and portal software products for healthcare payors, today announced that it has secured a $13 million investment commitment from Psilos Group, a leading healthcare venture capital and private equity firm.

"We believe that HealthEdge's HealthRules is the only software platform that meets the needs of today's healthcare marketplace," said Dr. Albert Waxman, senior managing member of Psilos Group. "The legacy systems currently in use at most health plans cannot respond to the evolving consumer-focused healthcare economy which demands support for personalized benefits and complex financial transaction management. HealthEdge is uniquely positioned to provide payor organizations of all sizes the ability to quickly offer the kinds of innovative products that the market demands and to make long overdue reductions in administrative overhead. Psilos is excited to extend our support of HealthEdge as it continues to expand its products and services."

"We are seeing unprecedented demand for our products," remarked Rob Gillette, CEO of HealthEdge. "The healthcare payor community has now realized that a contemporary software platform, built with the next generation of healthcare in mind, is no longer a luxury, but a necessity. We are extremely pleased to have Psilos Group as our investment partner."

HealthEdge will use the funds to increase the size of its business and to continue to invest in advanced product capabilities.

About HealthEdge

HealthEdge provides health plans, TPAs, PPOs and insurers of all sizes unique software products that enable them to compete in the new healthcare market. Payor organizations are able to pursue innovative, new strategies focused on increasing revenue, decreasing costs and improving the quality of healthcare. HealthEdge provides HealthRules(R), a next-generation, patented software platform for core administrative processes, business intelligence, and web self-service. The company is headquartered in Burlington, Massachusetts.

About Psilos Group

Psilos Group has been a successful healthcare venture capital and private equity firm since its founding in 1998. With over $500MM under management, Psilos focuses its investments across the healthcare services, healthcare information technology, and medical technology sectors. Psilos invests nationwide in businesses that are poised to create enduring market value by fundamentally improving the U.S. healthcare system. Our portfolio companies are sustainable and high-value businesses that have a demonstrated ability to reduce the costs of healthcare delivery, improve clinical quality and advance the alignment of payer, patient and provider incentives. Psilos has offices in New York, the San Francisco Bay Area and Santa Fe, New Mexico.

For more information, contact:

Maria Malavenda

SVP, Marketing

HealthEdge

781-419-6134

mmalavenda@healthedge.com


'/>"/>
SOURCE HealthEdge
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Seattle-Based Law Firm Williams Kastner Receives Significant Defense Verdict in Trade Secret Business Litigation Case
2. Arkion(R) Life Sciences Receives Crisis Exemption to US EPA Section 18 Approval in Mississippi and Tennessee to Market Avitec Corn Seed Treatment
3. QMed, Inc. Receives NASDAQ Delisting Letter
4. Ezra Susser, MD, DrPH, receives Distinguished Investigator Award from NARSAD
5. Compensation Risk Managers, LLC Receives Notice of Administrative Action by New York Workers Compensation Board
6. Tasker Products Receives USDA Consent to Begin Immediate Commercialization of Tasker Clear Throughout Entire Poultry Processing Operations
7. Draeger Receives Frost & Sullivan Consumer Award for Respiratory Protection
8. Easter Seals Receives $1 Million Donation From CVS Caremark Charitable Trust to Enhance Autism Services for Children
9. African medical research and training receives Wellcome boost
10. Sen. Robert Byrd Receives AOA Health Care Leadership Award
11. Reproductive Science Center of New England Receives Ambulatory Health Care Accreditation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2016)... ... May 26, 2016 , ... Despite last week’s media reports hinting ... and company to wait until March 2017 for an interest rate increase, according to ... College of Business. , “The Federal Open Market Committee (FOMC) dot charts are of ...
(Date:5/26/2016)... (PRWEB) , ... May 26, 2016 , ... ... in intellectual property (IP) to its specialty academic programs. , Answering to the ... college’s existing certificate programs in health law, and environmental and land use law. ...
(Date:5/26/2016)... ... May 26, 2016 , ... There are nearly 14.5 ... 32 million cancer survivors worldwide. On Sunday, June 5, 2016, communities around the world ... Cancer Survivors Day®. , National Cancer Survivors Day® is an annual worldwide Celebration ...
(Date:5/26/2016)... ... 2016 , ... In an effort to provide hair restoration information to the widest possible audience, ... who do not use the app. Dr. Mohebi, the founder of Parsa Mohebi Hair Restoration, ... . , Dr. Mohebi says, “The positive response to the Snapchat videos we started ...
(Date:5/26/2016)... ... , ... North Cypress Medical Center hosted its 9th Annual Spring ... the help of community partners, the event organizers raised $45,000 for the Lone ... members and their families through health, wellness, and therapeutic support. , A special ...
Breaking Medicine News(10 mins):
(Date:5/25/2016)... YORK , May 25, 2016  According to ... reached $381 billion in 2015.  Though these are ... plenty of opportunity for success for companies that ... in search of new growth prospects medical device ... on research and development (R&D) than do companies ...
(Date:5/25/2016)... MedDay, a biotechnology company focused on the treatment ... "High doses of biotin in progressive multiple sclerosis: extension phase ... Ayman Tourbah , Principal Investigator of the Phase 3 ... Neurology (EAN) in Copenhagen, Denmark . The ... on Sunday, 29 May 2016 from 14:45 to 16:15 CEST ...
(Date:5/24/2016)... May 24, 2016   ... beide primären Endpunkte und demonstriert Ebenbürtigkeit ... ‚ausgezeichneter plus guter , ... ,      (Logo: http://photos.prnewswire.com/prnh/20130829/633895-a ... neue positive Daten von der MORA-Studie der Phase ...
Breaking Medicine Technology: